Ebaa Al Ozairi Real-world data from the Dasman Diabetes Institute in Kuwait published in Diabetes, Obesity and Metabolism examined changes in body weight, HbA1c and other cardiometabolic factors for adults with overweight and type 1 diabetes who were prescribed liraglutide (Saxenda/Victoza, Novo Nordisk), semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Mounjaro/Zepbound, Eli Lilly)
That closes out the two-day vote with 6 of 7 peptides backed including yesterday's BPC-157, KPV, TB-500, and MOTS-c
Of course, even though the FDA banned it from one aisle of the drug store, it still may be available on another, in the form of tonic water
It's the only way to ensure the compound you're studying is exactly what it's supposed to be, allowing you to trust your findings
An iv infusion sends iv fluids, vitamins, and minerals straight into the bloodstream